Business Wire

Ancora Heart Receives IDE Approval for CorCinch-HF Pivotal Study of the AccuCinch® Ventricular Restoration System

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart has developed the AccuCinch Ventricular Restoration System ...
Business Wire

Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network SANTA CLARA, Calif. & ALISO VIEJO ...
BioWorld

Ancora Heart gets FDA nod for Accucinch pivotal trial

The U.S. FDA has greenlighted Ancora Heart Inc.’s IDE request to conduct the Corcinch-HF pivotal clinical trial. The study is intended to demonstrate the safety and effectiveness of the Accucinch ...
MD&M East

Ancora Heart Has Raised $80M to Address HF

Ancora Heart, a private company focused on the treatment of heart failure, has raised an $80 million equity financing. The Santa Clara, CA-based company is developing the AccuCinch Ventricular ...
MD&M East

Tales from TCT 2019: Ancora’s Heart Felt Data

A stronger and more experienced Ancora Heart entered into the 31 st Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation this past ...